Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: J Clin Gastroenterol. 2017 Feb;51(2):e11–e16. doi: 10.1097/MCG.0000000000000591

Figure 4. The combination of ATRA and UDCA altered the serum lipid profile.

Figure 4

Subjects from one of the enrolling sites (N=7) had lipid levels available for analysis.

Panel 4A: The median serum LDL level increased at week 12 but did not achieve significance (112±60 vs. 151±51 mg/dL, p=.1). Panel 4B: The median serum HDL level significantly decreased at week 12 (56±21 vs. 41±11 mg/dL, p=.03). Panel 4C: The median serum triglyceride level significantly increased at week 12 (79±31 vs. 136±45 mg/dL, p=.02).